SARAH MASTEN: Open Payments
NPI 1336664481 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $218 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $33 |
| ABBVIE INC. | 1 | $31 |
| Tris Pharma Inc | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: INGREZZA, VRAYLAR, Dyanavel XR, COBENFY, SPRAVATO, CAPLYTA.
Industry payments across CO — which companies pay providers there.
